관류 시스템 시장 규모, 점유율, 성장 분석 : 연령층별, 용도별, 최종사용자별, 지역별 - 업계 예측(2026-2033년)

Global Perfusion System Market size was valued at USD 1.34 Billion in 2024 and is poised to grow from USD 1.39 Billion in 2025 to USD 1.89 Billion by 2033, growing at a CAGR of 3.9% during the forecast period (2026-2033).

The global perfusion system market is essential in medical and biomedical research, notably for organ transplantation and cellular studies. These specialized devices enable the controlled flow of oxygenated and nutrient-rich fluids through biological tissues or organs outside the body, crucial for maintaining organ viability during transport and laboratory experiments. The increasing demand for organ transplants drives market growth, as perfusion systems are vital for preserving and assessing donor organs, ultimately enhancing transplant success rates. Advances in perfusion technology, such as normothermic perfusion, allow for longer maintenance and better organ viability assessments. Additionally, these systems play a critical role in pharmaceutical and biotechnology research by facilitating cell and tissue culturing, thereby supporting disease mechanism studies and novel treatment developments. The market is poised for continued growth as investments in advanced technologies and research initiatives expand.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Perfusion System market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Perfusion System Market Segments Analysis

Global Perfusion System Market is segmented by Age Group, Application, End User and region. Based on Age Group, the market is segmented into Adults and Pediatrics. Based on Application, the market is segmented into Cardiopulmonary Perfusion System, Cell Perfusion System, Ex-Vivo Organ Perfusion System, Extracorporeal Membrane Oxygenation (ECMO) and Isolated Organ Perfusion Systems. Based on End User, the market is segmented into Hospitals & ASCs, Specialty Clinics and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Perfusion System Market

The rising incidence of organ failure, coupled with a heightened demand for transplantable organs, significantly propels the Global Perfusion System market. These advanced systems are crucial for the preservation and evaluation of donor organs, thereby enhancing the overall success rates of transplantation procedures. As the healthcare sector focuses on improving outcomes for patients in need of transplants, the reliance on perfusion technologies becomes increasingly vital. This trend underscores the importance of effective organ management strategies, driving innovation and investment in perfusion devices to meet the growing needs within the transplant community. Overall, these factors contribute to a dynamic and expanding market landscape.

Restraints in the Global Perfusion System Market

The Global Perfusion System market faces significant challenges due to stringent regulatory requirements that necessitate adherence to rigorous standards for safety and efficacy. These compliance mandates can impede the pace of innovation and delay the introduction of new perfusion technologies into the market. As companies strive to meet these regulations, the often lengthy and complex approval processes can hinder timely access to advanced solutions. Consequently, the demand for enhanced perfusion systems may be stifled, affecting overall market growth and the ability to respond swiftly to evolving healthcare needs and technological advancements in the field.

Market Trends of the Global Perfusion System Market

The global market for perfusion systems is witnessing significant growth driven by the increasing adoption of normothermic perfusion techniques. This innovative approach, which maintains donor organs at physiological temperatures during transport, is revolutionizing organ preservation and assessment, leading to enhanced viability and improved transplant success rates. As healthcare professionals and transplant centers recognize the potential benefits of extended protection times and better evaluations of organ function, demand for advanced perfusion technology is on the rise. This trend is also fueled by ongoing research and development efforts aimed at optimizing perfusion solutions, further solidifying normothermic perfusion's role in transplantation and critical care.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Perfusion System Market Size by Age Group & CAGR (2026-2033)

• Market Overview
• Adults
• Pediatrics

Global Perfusion System Market Size by Application & CAGR (2026-2033)

• Market Overview
• Cardiopulmonary Perfusion System
  • Oxygenators
  • Heart-Lung Machine
  • Perfusion Pumps
  • Cannula
  • Monitoring System
  • Others
  • Arterial Filters
  • Reservoirs
  • Data Management Systems
  • Cardioplegia Delivery Systems
  • Heat Exchangers
  • Accessories
• Cell Perfusion System
  • Bioreactor Perfusion System
  • Microfluidic Perfusion System
  • Gravity/Pressure-driven Perfusion System
  • Small Mammal Organ Perfusion System
• Ex-Vivo Organ Perfusion System
  • Hypothermic
  • Normothermic
• Extracorporeal Membrane Oxygenation (ECMO)
• Isolated Organ Perfusion Systems

Global Perfusion System Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals & ASCs
• Specialty Clinics
• Others

Global Perfusion System Market Size & CAGR (2026-2033)

• North America (Age Group, Application, End User)
  • US
  • Canada
• Europe (Age Group, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Age Group, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Age Group, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Age Group, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• ICU Medical (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Delcath Systems (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fresenius Medical Care (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Getinge AB (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LivaNova (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Edwards Lifesciences (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nipro Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CytoSorbents Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Spectrum Medical (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurosets (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biomedica (Austria)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Soma Technology (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations